Zhu, Weiwei,
Luo, Wu,
Han, Jibo,
Zhang, Qiuyan,
Ji, Lijun,
Samorodov, Aleksandr V.,
Pavlov, Valentin N.,
Zhuang, Zaishou,
Yang, Daona,
Yin, Lina,
Huang, Lijiang,
Liang, Guang (2023) the differential effects and potential
target of Sch B. ALI was induced by intratracheal administration of LPS
the potential of stromal vascular fraction (SVF) cell
therapy as a novel regenerative treatment for ICH. SVF
Li, Xiang,
Yin, Lina,
Liao, Jing,
Yang, Jun,
Cai, Binhao,
Yu, Yiming,
Su, Sijia,
Du, Zhiteng,
Li, Xiaobo,
Zhou, Ying,
Chen, Pan,
Cho, Won-Jea,
Chattipakorn, Nipon,
Samorodov, Aleksandr V.,
Pavlov, Valentin N.,
Zhang, Fengzhi,
Liang, Guang,
Tang, Qidong (2023) , immunoprecipitation, and molecular docking indicated that L26
targeted MD-2 protein and competed with LPS to bind
Mingyu, He,
Gege, Yan,
Yang, Wang,
Gong, Rui,
Lei, Hong,
Yu, Shuting,
He, Xiaoqi,
Li, Guanghui,
Du, Weijie,
Ma, Tianshuai,
Gao, Manqi,
Yu, Meixi,
Liu, Shenzhen,
Xu, Zihang,
Idiiatullina, Elina,
Zagidullin, Naufal,
Pavlov, Valentin,
Cai, Benzhi,
Yuan, Ye,
Yang, Lei (2021) -emitting diodes (LED)-based
therapy has emerged as a new promising approach for several diseases. However